No Subsidies for Gender Transition Procedures Act
- Bill Number
- H.R. 3205
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-05: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-12-05T22:59:07Z
AI-Generated Summary
Purpose of the Legislation
This bill, titled the "No Subsidies for Gender Transition Procedures Act," aims to prevent federal tax deductions and government funding for medical procedures related to gender transition. Gender transition refers to the process where a person changes their presentation or identity from their biological sex (defined as male or female based on reproductive biology at conception) to a different gender identity, often involving physical changes like hormone treatments or surgeries.
Key Provisions
- Tax Deduction Denial (Section 2): Amends the Internal Revenue Code to exclude "gender transition procedures" from qualifying as deductible medical expenses. These procedures include:
- Hormone treatments, such as puberty blockers (drugs that delay normal puberty), or high doses of hormones like testosterone or estrogen to alter physical appearance.
- Surgeries, such as removal or alteration of sexual organs (e.g., mastectomy, vaginoplasty, phalloplasty), sterilization, or cosmetic changes to facial or body features to align with a non-biological gender identity.
- Exclusions apply for treatments related to verifiable medical conditions, like disorders of sex development (conditions where a person's sex characteristics are ambiguous due to genetic or hormonal issues), infections or injuries from prior procedures, life-threatening physical illnesses, reversal surgeries to restore biological sex, precocious puberty (early puberty), or male circumcision.
- Medicaid Funding Ban (Section 3): Prohibits federal Medicaid payments (a joint federal-state health program for low-income people) for gender transition procedures, including administrative costs for providing them. Uses the same definitions and exclusions as the tax provision.
- CHIP Funding Ban for Minors (Section 4): Bars federal funding under the Children's Health Insurance Program (CHIP, which covers uninsured children in low-income families) for gender transition procedures on individuals under 18. Aligns with Medicaid's definitions.
- Medicare Funding Ban (Section 5): Excludes gender transition procedures from coverage under Medicare (federal health insurance for people 65 and older or with certain disabilities).
- Essential Health Benefits Exclusion (Section 6): Amends the Affordable Care Act (ACA) to prevent gender transition procedures from being included as "essential health benefits" (core services that most health insurance plans must cover without extra cost-sharing).
- Effective Dates: Tax changes apply to tax years after enactment; all other changes apply to services provided after enactment.
- Definitions: "Sex" is biologically determined as male (sperm-producing reproductive system) or female (egg-producing reproductive system). The bill emphasizes physical, biological criteria over self-identified gender.
Significant Changes to Existing Law
- Tax Code (Internal Revenue Code Section 213): Previously, medical expenses exceeding 7.5% of adjusted gross income could be deducted if they treated illness or injury; this adds an explicit exclusion for gender transition procedures, treating them as non-medical for deduction purposes.
- Social Security Act (Medicaid, CHIP, Medicare): These programs previously covered gender-affirming care in many cases if deemed medically necessary; the bill introduces outright prohibitions on federal funding, overriding state decisions to include such coverage.
- Affordable Care Act (Section 1302): Essential health benefits were previously defined by states within federal guidelines, allowing inclusion of gender transition care; this mandates exclusion, limiting what insurers must cover.
Potential Impacts
- On Citizens: Individuals seeking gender transition care (primarily transgender people) may face increased out-of-pocket costs, as they lose tax deductions and federal insurance coverage. This could limit access, especially for low-income, elderly, or child populations reliant on Medicaid, CHIP, or Medicare. Those with excluded medical conditions (e.g., intersex individuals) remain eligible for related treatments.
- On Government Agencies: The Internal Revenue Service (IRS) must update tax forms and guidance to enforce deduction denials. The Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid Services (CMS) will need to revise reimbursement rules, potentially reducing federal spending on these procedures but increasing administrative workloads for compliance monitoring. States administering Medicaid/CHIP may see shifts in funding formulas.
- On International Relations: No direct impacts, as the bill focuses on domestic U.S. health and tax policy.
Main Stakeholders Affected
- Transgender Individuals and Families: Primary group impacted, as they may lose financial support for care aligned with their gender identity.
- Healthcare Providers: Doctors, surgeons, and clinics offering gender-affirming treatments could see reduced reimbursements from federal programs, affecting service availability.
- Low-Income and Vulnerable Populations: Medicaid and CHIP beneficiaries, including children and seniors on Medicare, who might otherwise qualify for such care.
- Federal and State Governments: Agencies like HHS, CMS, and IRS handle implementation; states may need to adjust budgets or seek alternative funding.
- Insurers and Employers: ACA plans cannot include these procedures as essential benefits, potentially altering private insurance offerings.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: The bill's detailed definitions could lead to disputes over what qualifies as a "gender transition procedure" versus excluded medical care, requiring court interpretations (e.g., via physician certifications). It may conflict with existing state laws mandating coverage for gender-affirming care, prompting federal-state legal challenges.
- Constitutional Implications: Potential violations of the Equal Protection Clause of the 14th Amendment, as it differentiates treatment based on gender identity or sex, which courts have increasingly viewed as suspect classifications (similar to rulings in cases like Bostock v. Clayton County, extending protections to transgender people). It could also raise due process concerns if it limits access to care deemed medically necessary by professionals.
- Political Implications: The legislation reflects debates over gender identity and federal funding priorities, likely sparking partisan divides in Congress and public discourse. If enacted, it could influence broader policy on LGBTQ+ rights and healthcare equity, with possible overrides or amendments in future sessions.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Tenney, Claudia [R-NY-24]
Cosponsors (3)
Rep. Crenshaw, Dan [R-TX-2], Rep. Roy, Chip [R-TX-21], Rep. Steube, W. Gregory [R-FL-17]
Recent Actions
- 2025-05-05: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-05-05: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-05-05: Introduced in House
- 2025-05-05: Introduced in House
Bill Versions
- No Subsidies for Gender Transition Procedures Act — issued 2025-05-05 — PDF (17 pages)